|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Pioneer Surgical Technology Inc., a manufacturer of spinal and orthopedic implants. |
|---|---|
| Transferring Party | Angstrom Medica, Inc., a developer of nanocrystalline calcium phosphate technology -- NanOss™. |
| Sector | Biopharmaceuticals |
| Date | October 24, 2007 |
| Analysis Angstrom is the first company to obtain FDA approval for a nanotechnology device that can remodel over time into human bone. NanOss has potential application in trauma, spine and general orthopedic markets. Also in 2007, PST acquired Encelle, Inc., which develops tissue regeneration products. Terms not disclosed. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |